DexCom Inc (OQ:DXCM)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 6340 Sequence Dr
SAN DIEGO CA 92121-4356
Tel: 1-858-2000200
Website: https://www.dexcom.com
IR: See website
<
Key People
Kevin R. Sayer
Chairperson of the Board, President, Chief Executive Officer
Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Jacob Steven Leach
Executive Vice President, Chief Operating Officer
Sadie M. Stern
Chief Human Resources Officer, Executive Vice President
Michael J. Brown
Executive Vice President, Chief Legal Officer
Matthew Vincent Dolan
Executive Vice President - Strategy, Corporate Development and Dexcom Labs
Teri L. Lawver
Executive Vice President, Chief Commercial Officer
   
Business Overview
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient's compatible mobile device.
Financial Overview
For the three months ended 31 March 2024, DexCom Inc revenues increased 24% to $921M. Net income increased from $48.6M to $146.4M. Revenues reflect Distributor segment increase of 26% to $778.8M, Direct segment increase of 16% to $142.2M, United States segment increase of 24% to $653.2M, Outside of United states segment increase of 24% to $267.8M. Basic Earnings per Share excluding Extraordinary Items increased from $0.13 to $0.38.
Employees: 9,600 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $45,982M as of Mar 31, 2024
Annual revenue (TTM): $3,802M as of Mar 31, 2024
EBITDA (TTM): $865.10M as of Mar 31, 2024
Net annual income (TTM): $639.30M as of Mar 31, 2024
Free cash flow (TTM): $583.50M as of Mar 31, 2024
Net Debt Last Fiscal Year: N/A
Shares outstanding: 397,683,837 as of Apr 18, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.